Nine-amino-acid transactivation domain: establishment and prediction utilities S Piskacek, M Gregor, M Nemethova, M Grabner, P Kovarik, M Piskacek Genomics 89 (6), 756-768, 2007 | 167 | 2007 |
Conditional knockdown of hMRS2 results in loss of mitochondrial Mg + uptake and cell death M Piskacek, L Zotova, G Zsurka, RJ Schweyen Journal of cellular and molecular medicine 13 (4), 693-700, 2009 | 99 | 2009 |
Functional Analysis of the Zn2Cys6Transcription Factors Oaf1p and Pip2p: DIFFERENT ROLES IN FATTY ACID INDUCTION OF β-OXIDATION INSACCHAROMYCES CEREVISIAE U Baumgartner, B Hamilton, M Piskacek, H Ruis, H Rottensteiner Journal of biological chemistry 274 (32), 22208-22216, 1999 | 82 | 1999 |
Functionally suppressive CD8 T regulatory cells are increased in patients with multiple myeloma: a cause for immune impairment KR Muthu Raja, L Kubiczkova, L Rihova, M Piskacek, P Vsianska, ... PloS one 7 (11), e49446, 2012 | 58 | 2012 |
The 9aaTAD transactivation domains: from Gal4 to p53 M Piskacek, M Havelka, M Rezacova, A Knight PloS one 11 (9), e0162842, 2016 | 54 | 2016 |
A novel 9-amino-acid transactivation domain in the C-terminal part of Sox18 J Sandholzer, M Hoeth, M Piskacek, H Mayer, R de Martin Biochemical and biophysical research communications 360 (2), 370-374, 2007 | 40 | 2007 |
Predicting the Function and Subcellular Location of Caenorhabditis elegans Proteins Similar to Saccharomyces cerevisiae -Oxidation Enzymes A Gurvitz, S Langer, M Piskacek, B Hamilton, H Ruis, A Hartig Yeast 1 (3), 188-200, 2000 | 39 | 2000 |
Shared structural features of the 9aaTAD family in complex with CBP M Piskacek, A Vasku, R Hajek, A Knight Molecular BioSystems 11 (3), 844-851, 2015 | 27 | 2015 |
The 9aaTAD is exclusive activation domain in Gal4 M Piskacek, M Havelka, M Rezacova, A Knight PloS one 12 (1), e0169261, 2017 | 20 | 2017 |
The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinases B Fafilek, L Balek, MK Bosakova, M Varecha, A Nita, T Gregor, ... Science signaling 11 (548), eaap8608, 2018 | 18 | 2018 |
Clozapine reverses dysfunction of glutamatergic neurons derived from clozapine-responsive schizophrenia patients H Hribkova, O Svoboda, E Bartecku, J Zelinkova, J Horinkova, L Lacinova, ... Frontiers in Cellular Neuroscience 16, 830757, 2022 | 11 | 2022 |
The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with valines and intron reservoirs M Piskacek, M Havelka, K Jendruchova, A Knight, LP Keegan Cellular and molecular life sciences 77, 1793-1810, 2020 | 11 | 2020 |
Blocking of EphA2 on endometrial tumor cells reduces susceptibility to Vδ1 gamma-delta T-cell-mediated killing R Hudecek, B Kohlova, I Siskova, M Piskacek, A Knight Frontiers in Immunology 12, 752646, 2021 | 9 | 2021 |
Nuclear hormone receptors: Ancient 9aaTAD and evolutionally gained NCoA activation pathways M Piskacek, M Havelka, K Jendruchová, A Knight The Journal of Steroid Biochemistry and Molecular Biology 187, 118-123, 2019 | 9 | 2019 |
The 9aaTAD activation domains in the Yamanaka transcription factors Oct4, Sox2, Myc, and Klf4 M Piskacek, T Otasevic, M Repko, A Knight Stem Cell Reviews and Reports 17 (5), 1934-1936, 2021 | 6 | 2021 |
Plasmacytoid dendritic cells in patients with MGUS and multiple myeloma A Knight, L Rihova, R Kralova, M Penka, Z Adam, L Pour, M Piskacek, ... Journal of Clinical Medicine 10 (16), 3717, 2021 | 6 | 2021 |
9aaTAD Prediction result (2006) M Piskacek Nature Precedings, 1-1, 2009 | 6 | 2009 |
Universal two‐point interaction of mediator KIX with 9aaTAD activation domains A Hofrova, P Lousa, M Kubickova, J Hritz, T Otasevic, M Repko, A Knight, ... Journal of Cellular Biochemistry 122 (10), 1544-1555, 2021 | 4 | 2021 |
Cryptic inhibitory regions nearby activation domains A Knight, M Piskacek Biochimie 200, 19-26, 2022 | 3 | 2022 |
Gal4 activation domain 9aaTAD could be inactivated by adjacent mini-inhibitory domain and reactivated by distal re-activation domain M Piskacek, M Havelka, M Rezacova, A Knight bioRxiv, 110882, 2017 | 3 | 2017 |